Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells
暂无分享,去创建一个
M. Bouvet | R. Hoffman | Jun Ho Park | B. Clary | Shree Ram Singh | Ming Zhao | T. Higuchi | K. Miyake | Jun Yamamoto | Zhiying Zhang | Sahar Razmjooei | H. Oshiro | J. Reynoso | Norihiko Sugisawa
[1] I. Endo,et al. Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model. , 2019, Biochemical and biophysical research communications.
[2] M. Bouvet,et al. Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein , 2018, AntiCancer Research.
[3] M. Unno,et al. Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer. , 2018, Cancer letters.
[4] S. Dry,et al. Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model , 2017, Oncotarget.
[5] R. Hoffman,et al. Analysis of Stroma Labeling During Multiple Passage of a Sarcoma Imageable Patient‐Derived Orthotopic Xenograft (iPDOX) in Red Fluorescent Protein Transgenic Nude Mice , 2017, Journal of cellular biochemistry.
[6] S. Ishihara,et al. Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer , 2017, Annals of Surgical Oncology.
[7] R. Hoffman,et al. Labeling the Stroma of a Patient‐Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft‐Tissue Sarcoma With Red Fluorescent Protein for Rapid Non‐Invasive Imaging for Drug Screening , 2017, Journal of cellular biochemistry.
[8] A. Govindarajan,et al. Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy , 2015, Clinics in Colon and Rectal Surgery.
[9] R. Hoffman. Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts , 2015, Nature Reviews Cancer.
[10] K. Takabe,et al. Current treatment options for colon cancer peritoneal carcinomatosis. , 2014, World journal of gastroenterology.
[11] I. Endo,et al. Efficacy of Salmonella typhimurium A1‐R Versus Chemotherapy on a Pancreatic Cancer Patient‐Derived Orthotopic Xenograft (PDOX) , 2014, Journal of cellular biochemistry.
[12] M. Bouvet,et al. Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice. , 2012, Anticancer research.
[13] J. Coebergh,et al. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population‐based study , 2011, International journal of cancer.
[14] M. Hutteman,et al. Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin α(v)β(3) expression in a syngeneic rat model. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[15] F. Kwiatkowski,et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] H. van Tinteren,et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Robert M Hoffman,et al. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. , 2003, The Journal of surgical research.
[18] Y. Taki,et al. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. , 2002, American journal of surgery.
[19] B. Shmookler,et al. Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy , 1993, Diseases of the colon and rectum.
[20] R. Hoffman,et al. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Hoffman. Patient-Derived Mouse Models of Cancer , 2017, Molecular and Translational Medicine.